Features
Latest World Pharmaceuticals Feature
Clinical trial materials each have unique packaging requirements, and...
> read more
Choosing the right central lab Central laboratories have become an important part of running global clinical trials in Europe and the US. With the rapid increase in the number of studies conducted in China and...
Rise to the challenge Running a clinical trial can be a difficult process at the best of times, but the level of complexity can be orders of magnitude higher when it comes to rare disease research....
Clinical trials and tribulations Even though they’re often a vital conduit between the drug and patient, ancillary supplies are sometimes seen as an afterthought for sponsors, who have been known to request items at...
Cash in on opportunity Adaptive trial designs have enabled clinical research to keep up with Covid-19, but their operational costs and complexities might be harder to justify once the pandemic has passed...
Trial at home Clinical trials have historically been done at hospitals or clinics, with subjects and researchers convening to get results. But with the rise of new technology – to say nothing of...
Next-gen vaccines The lockdowns of 2020 and beyond led to economic disruption on a scale not seen outside of wartime, and the imperative to reduce some of this damage led to the fastest vaccines...
Reap the benefits Clinical study protocols are important cornerstones on the journey of collecting the clinical data needed to elucidate the benefit-risk profile of medical treatments/devices....
The smart money Smart packaging offers huge value to the whole of the supply chain. There are a number of recent innovations that can help optimise monitoring. Louise Thomas speaks to Ruud van der...
Counterfeit and proper The health crisis created by Covid-19 has created further opportunities for black market medicines to be sold to worried populations. Jackie Pullman explores how Novartis, through...
Waste not, want not The health sector is responsible for an estimated 4.4% of global greenhouse gas emissions – the vast majority of which originate in the supply chain. One of the easiest ways to...
Mind the skills gap There’s a skills shortage in the world of cell and gene therapy. This isn’t news; the problem has endured for years without a solution – but could that be because there isn’t one?...
Counterfeit and proper The health crisis created by Covid-19 has created further opportunities for black market medicines to be sold to worried populations. Jackie Pullman explores how Novartis, through...
Big issues, nano solutions Proteins and peptides have come a long way since their medicinal potential was first realised, and yet oral delivery still faces age-old challenges. Andrew Tunnicliffe speaks...
Tech transfer: from bottleneck to boon Outsourcing arrangements have been crucial to the roll-out of Covid-19 vaccines, and the pandemic has focused the industry’s gaze on the importance of broader collaboration,...
Hashgraphs for healthcare Developing Covid-19 vaccines was a huge challenge, but successfully distributing them is another. Long-touted as revolutionary for pharma, distributed ledger technology has the...
The best shot The validation of Covid-19 vaccines will go down in history as a turning point during this pandemic, but with highly specific storage and transportation requirements, the roll-outs...
Weighing the risks Though vaccines are playing a huge role in the fight against Covid-19, some hesitancy remains. A few people have died from allergic reactions and blood clots likely sparked by the...
Chain reaction Covid-19 has highlighted the need for pharmaceutical supply chains to be resilient and flexible. Building them to be agile and adaptive mitigates risk from sudden changes in supply...
Come together Until relatively recently, patient engagement involved very few conversations with patients themselves. Good practice was anecdotal rather than the norm. Elly Earls talks to...
View all features A-Z
